Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Міцубісі Танабе Фарма КорпорейшнfiledCriticalМіцубісі Танабе Фарма Корпорейшн
Priority claimed from PCT/JP2007/073729external-prioritypatent/WO2008069327A1/en
Publication of UA93135C2publicationCriticalpatent/UA93135C2/ru
A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
Crystalline form of 1-chloro-4-(β -D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
Processes for the preparation of sglt inhibitors, crystalline forms of 1– (d – β ––– glucopyranosyl) –4 – chloro – 3– [5– (6-fluoro-3-pyridyl) –2-thienylmethyl] benzene, pharmaceutical preparations containing them and uses In them
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
Combinação anti-tumor, constituída por derivados substituídos de acriloil-distamicina e anticorpos que inibem os factores de crescimento ou os seus receptores